GSK urges FDA to tighten regulation of dietary supplements

06/30/2008 | Star-Ledger (Newark, N.J.), The

GlaxoSmithKline has filed a petition asking the FDA to require makers of weight-loss supplements to conduct premarket testing for safety or efficacy and obtain regulatory approval for their products. If approved, the proposed changes could help Glaxo fend off competition for over-the-counter Alli but would also "make it illegal to market dietary supplements for weight loss," said Michael McGuffin, president of the American Herbal Products Association.

View Full Article in:

Star-Ledger (Newark, N.J.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC